FIELD: medicine.
SUBSTANCE: as active agents, the composition contains triazavirin in an amount of 1.5-2.0 wt % and sea buckthorn oil in an amount of 1.5 - 2.0 wt %, whereas a gel base represents silicone glycerohydrogel Si(C3H7O3)4·6C3H8O3·24H2O.
EFFECT: invention has high therapeutic activity and an increased rate of pathological element epithelisation alongside with no adverse side effect.
5 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR LOCAL TREATMENT OF PERIODONTAL DISEASES | 2011 |
|
RU2491061C2 |
PREPARATION FOR TREATING PERIODONTITIS | 2015 |
|
RU2604128C1 |
AGENT FOR TREATING INFLAMMATORY ORAL DISEASES AND METHOD OF TREATING INFLAMMATORY ORAL DISEASES | 2011 |
|
RU2470640C1 |
AGENT FOR TREATING PERIODONTITIS AND A METHOD OF TREATING PERIODONTITIS | 2020 |
|
RU2729428C1 |
AGENT FOR TREATING PAERIODONTAL AND MUCOSAL DISEASES WITH REPARATIVE PROPERTIES | 2018 |
|
RU2671512C1 |
METHOD OF TREATING PERIODONTITIS AND ORAL MUCOSAL DISEASES ASSOCIATED WITH HELICOBACTER INFECTION, AND METHOD FOR USING IT | 2014 |
|
RU2549445C1 |
MEANS FOR TREATING INFLAMMATORY DISEASES OF PARODONTIUM | 2014 |
|
RU2566073C1 |
AGENT FOR LOCAL TREATMENT OF PERIODONTITIS AND METHOD OF TREATMENT OF PERIODONTITIS | 2022 |
|
RU2802822C1 |
MEANS FOR FIXATION OF DETACHABLE DENTAL PROSTHESIS | 2014 |
|
RU2558934C1 |
METHOD OF TRAINING MUCOPERIOSTEAL FLAP FOR SURGICAL TREATMENT OF PERIODONTAL INFLAMMATORY DISEASES | 2009 |
|
RU2414868C1 |
Authors
Dates
2015-08-20—Published
2014-01-09—Filed